You are here

Core Therapeutic Areas

To strengthen our scientific core, we are investing in areas where we see the greatest opportunity and where we believe we can deliver the best value. We also forge novel partnerships that allow us to access the best science.

While we continue to pursue and invest in additional therapies in early and late stages of clinical development (see Worldwide Research & Development (WRD) and Biopharmaceuticals pages), the following are Pfizer's priority R&D therapeutic areas:

Inflammation & Immunology

Internal Medicine
   Metabolic Diseases

   Neurodegenerative Diseases

Oncology

Rare Disease

Vaccines